The relationship of phthalocyanine 4 (Pc 4) concentrations measured noninvasively to outcome of Pc 4 photodynamic therapy in mice

Photochemistry and Photobiology

Volumn 85, Issue 4, 2009, Pages 1011-1019

  Bai, Lihua ^a,b   Guo, Jianxia ^a,b   Bontempo Iii, Franklin A ^b   Eiseman, Julie L ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOLE DERIVATIVE; PHTHALOCYANINE PC 4;

ANIMAL; ARTICLE; BREAST TUMOR; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MOUSE; MOUSE MUTANT; PHOTOCHEMOTHERAPY; XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; INDOLES; MICE; MICE, SCID; PHOTOCHEMOTHERAPY; TRANSPLANTATION, HETEROLOGOUS;

MUS;

EID: 67650960978     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-1097.2009.00542.x     Document Type: Article

References (49)

1. Sibata, C. H., V. C. Colussi, N. L. Oleinick T. J. Kinsella (2000) Photodynamic therapy: A new concept in medical treatment. Braz. J. Med. Biol. Res. 33, 869 880. (Pubitemid 30683384)
2. Sharman, W. M., C. M. Allen J. E. van Lier (1999) Photodynamic therapeutics: Basic principles and clinical applications. Drug Discov. Today 4, 507 517. (Pubitemid 29497854)
3. Stewart, F., P. Baas W. Star (1998) What does photodynamic therapy have to offer radiation oncologists (or their cancer patients)? Radiother. Oncol. 48, 233 248. (Pubitemid 28555657)
4. Dougherty, T. J., C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan Q. Peng (1998) Photodynamic therapy. J. Natl Cancer Inst. 90, 889 905. (Pubitemid 28304157)
5. Dolmans, D. E., D. Fukumura R. K. Jain (2003) Photodynamic therapy for cancer. Nat. Rev. Cancer 3, 380 387. (Pubitemid 37328858)
6. Wolfsen, H. C., L. L. Hemminger, M. B. Wallace K. R. Devault (2004) Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer. Aliment. Pharmacol. Ther. 20, 1125 1131. (Pubitemid 39657946)
7. Huang, Z. (2005) A review of progress in clinical photodynamic therapy. Technol. Cancer Res. Treat. 4, 283 293. (Pubitemid 40807688)
8. Ackroyd, R., N. J. Brown, M. F. Davis, T. J. Stephenson, S. L. Marcus, C. J. Stoddard, A. G. Johnson M. W. Reed (2000) Photodynamic therapy for dysplastic Barrett's oesophagus: A prospective, double blind, randomized, placebo controlled trial. Gut 47, 612 617. (Pubitemid 30809036)
9. Kelty, C. J., R. Ackroyd, N. J. Brown, S. B. Brown M. W. Reed (2004) Comparison of high- vs low-dose 5-aminolevulinic acid for photodynamic therapy of Barrett's esophagus. Surg. Endosc. 18, 452 458. (Pubitemid 38524516)
10. Brown, S. B., E. A. Brown I. Walker (2004) The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. 5, 497 508. (Pubitemid 39069400)
11. Bai, L., E. Joseph, N. L. Oleinick, J. M. Mulvihill, D. K. Feyes J. L. Eiseman (2007) Use of optical pharmacokinetics system (OPS) for non-invasive measurement of phthalocyanine 4 (Pc 4) concentrations in mice bearing MDA-MB-231 xenografts. Proc. SPIE 6796, 67960L.
12. Colussi, V. C., D. K. Feyes, J. W. Mulvihill, Y. S. Li, M. E. Kenney, C. A. Elmets, N. L. Oleinick H. Mukhtar (1999) Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts. Photochem. Photobiol. 69, 236 241. (Pubitemid 129606912)
13. Whitacre, C. M., T. H. Satoh, L. Xue, N. H. Gordon N. L. Oleinick (2002) Photodynamic therapy of human breast cancer xenografts lacking caspase-3. Cancer Lett. 179, 43 49. (Pubitemid 34195652)
14. George, J. E., III., Y. Ahmad, D. Varghai, X. Li, J. Berlin, D. Jackowe, M. Jungermann, M. S. Wolfe, L. Lilge, A. Totonchi, R. L. Morris, A. Peterson, W. D. Lust, M. E. Kenney, C. L. Hoppel, J. Sun, N. L. Oleinick D. Dean (2005) Pc 4 photodynamic therapy of U87-derived human glioma in the nude rat. Lasers Surg. Med. 36, 383 389. (Pubitemid 40942153)
15. Oleinick, N. L., R. L. Morris I. Belichenko (2002) The role of apoptosis in response to photodynamic therapy: What, where, why, and how. Photochem. Photobiol. Sci. 1, 1 21. (Pubitemid 37069701)
16. Miller, J. D., E. D. Baron, H. Scull, A. Hsia, J. C. Berlin, T. McCormick, V. Colussi, M. E. Kenny, K. D. Cooper N. L. Oleinick (2007) Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: The case experience with preclinical mechanistic and early clinical-translational studies. Toxicol. Appl. Pharmacol. 224, 290 299. (Pubitemid 47575679)
17. van Veen, R. L. P., D. J. Robinson P. D. Siersema (2006) The importance of in situ dosimetry during photodynamic therapy of Barrett's esophagus. Gastrointest. Endosc. 64, 786 788. (Pubitemid 44573138)
18. Adili, F., R. G. Statius, S. van Eps G. M. LaMuraglia (1999) Significance of dosimetry in photodynamic therapy of injured arteries: Classification of biological responses. Photochem. Photobiol. 70, 663 668. (Pubitemid 129555839)
19. Cottrell, W. J., A. R. Oseroff T. H. Foster (2006) Portable instrument that integrates irradiation with fluorescence and reflectance spectroscopies during clinical photodynamic therapy of cutaneous disease. Rev. Sci. Instrum. 77, 064302.
20. Yu, G., T. Durduran, C. Zhou, T. C. Zhu, J. C. Finlay, T. M. Busch, S. B. Malkowicz, S. M. Hahn A. G. Yodh (2006) Real-time in situ monitoring of human prostate photodynamic therapy with diffuse light. Photochem. Photobiol. 82, 1279 1284. (Pubitemid 44702009)
21. Sheng, C., P. J. Hoopes, T. Hasan B. W. Pogue (2007) Photobleaching-based dosimetry predicts deposited dose in ALA-PpIX PDT of rodent esophagus. Photochem. Photobiol. 83, 738 748. (Pubitemid 46854943)
22. Mourant, J. R., I. J. Bigio, D. A. Jack, T. M. Johnson H. D. Miller (1997) Measuring absorption coefficients in small volumes of highly scattering media: Source-detector separations for which path lengths do not depend on scattering properties. Appl. Opt. 36, 5655 5661. (Pubitemid 127638525)
23. Mourant, J. R., T. M. Johnson, G. Los I. J. Bigio (1999) Non-invasive measurement of chemotherapy drug concentrations in tissue: Preliminary demonstrations of in vivo measurements. Phys. Med. Biol. 44, 1397 1417. (Pubitemid 29225668)
24. Kanick, S. C., J. L. Eiseman, E. Joseph, J. Guo R. S. Parker (2007) Noninvasive and nondestructive optical spectroscopic measurement of Motexafin Gadolinium in mouse tissues: Comparison to high-performance liquid chromatography. J. Photochem. Photobiol. B, Biol. 88, 90 104. (Pubitemid 47382612)
25. Kanick, S. C., J. Guo, E. Joseph, M. J. Egorin, R. S. Parker J. L. Eiseman (2006) Plasma pharmacokinetics and tissue distribution of the photodynamic therapy (PDT) agent, Pc4, in mice: Measurement comparison of optical pharmacokinetic system (OPS) with high performance liquid chromatography (HPLC). Proc. Am. Assoc. Cancer Res. 47, 1218.
26. Bonnett, R. G. Martinez (2001) Photobleaching of sensitisers used in photodynamic therapy. Tetrahedron 57, 9513 9547. (Pubitemid 33055636)
27. Rovers, J. P., L. M. de Jode, H. Rezzoug M. F. Grahn (2000) In vivo photodynamic characteristics of the near-infrared photosensitizer 5,10,15,20-tetrakis(M-hydroxyphenyl) bacteriochlorin. Photochem. Photobiol. 72, 358 364.
28. Finlay, J. C., S. Mitra, M. S. Patterson T. H. Foster (2004) Photobleaching kinetics of Photofrin in vivo and in multicell tumor spheroids indicate two simultaneous bleaching mechanisms. Phys. Med. Biol. 49, 4837 4860. (Pubitemid 39489928)
29. Dysart, J. S., G. Singh M. S. Patterson (2005) Calculation of singlet oxygen dose from photosensitizer fluorescence and photobleaching during mTHPC photodynamic therapy of MLL cells. Photochem. Photobiol. 81, 196 205. (Pubitemid 40327580)
30. Dysart, J. S. M. S. Patterson (2005) Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro. Phys. Med. Biol. 50, 2597 2616. (Pubitemid 40770642)
31. Bai, L., J. Guo, F. Bontempo J. Eiseman (2008) Efficacy of phthalocyanine 4 photodynamic therapy and non-invasive pharmacokinetics of Pc 4 in mice bearing MDA-MB-231 xenografts. Proc. Am. Assoc. Cancer Res. 49, 3317.
32. Lee, T. K., E. D. Baron T. H. Foster (2008) Monitoring Pc 4 photodynamic therapy in clinical trials of cutaneous T-cell lymphoma using noninvasive spectroscopy. J. Biomed. Opt. 13, 030507.
33. Wang, K. K., J. D. Wilson, M. E. Kenney, S. M. Mitra T. H. Foster (2007) Irradiation-induced enhancement of Pc 4 fluorescence and changes in light scattering are potential dosimeters for Pc4-PDT. Photochem. Photobiol. 83, 1056 1062. (Pubitemid 47438513)
34. Varghai, D., K. Azizuddin, Y. Ahmad, N. L. Oleinick D. Dean (2007) Fluorescence of Pc 4 in U87 cells following photodynamic therapy. Proc. SPIE 6424, 64242A.
35. Foster, T. H., R. S. Murant, R. G. Bryant, R. S. Knox, S. L. Gibson R. Hilf (1991) Oxygen consumption and diffusion effects in photodynamic therapy. Radiat. Res. 126, 296 303.
36. Iinuma, S., K. T. Schomacker, G. Wagnieres, M. Rajadhyaksha, M. Bamberg, T. Momma T. Hasan (1999) In vivo fluence rate and fractionation effects on tumor response and photobleaching: Photodynamic therapy with two photosensitizers in an orthotopic rat tumor model. Cancer Res. 59, 6164 6170. (Pubitemid 30035638)
37. Tsutsui, H., A. J. MacRobert, A. Curnow, A. Rogowska, G. Buonaccorsi, H. Kato S. G. Bown (2002) Optimisation of illumination for photodynamic therapy with mTHPC on normal colon and a transplantable tumour in rats. Lasers Med. Sci. 17, 101 109. (Pubitemid 34785448)
38. Müller, S., H. Walt, D. Dobler-Girdziunaite, D. Fiedler U. Haller (1998) Enhanced photodynamic effects using fractionated laser light. J. Photochem. Photobiol. B, Biol. 42, 67 70. (Pubitemid 28058543)
39. Eiseman, J. L., J. Lan, T. F. Lagattuta, D. R. Hamburger, E. Joseph, J. M. Covey M. J. Egorin (2005) Pharmacokinetics and pharmacodynamics of 17-demethoxy 17-[[(2-dimethylamino)ethyl]amino]geldanamycin (17DMAG, NSC 707545) in C.B-17 SCID mice bearing MDA-MB-231 human breast cancer xenografts. Cancer Chemother. Pharmacol. 55, 21 32.
40. Egorin, M. J., E. G. Zuhowski, D. L. Sentz, J. M. Dobson, P. S. Callery J. L. Eiseman (1999) Plasma pharmacokinetics and tissue distribution in CD2F1 mice of Pc 4 (NSC 676418), a silicone phthalocyanine photodynamic sensitizing agent. Cancer Chemother. Pharmacol. 44, 283 294.
41. Cox Proportional Hazards Survival Regression by John C. Pezzullo. Available at: http://statpages.org/prophaz.html. Accessed on 22 August 2008.
42. Samkoe, K. S., M. S. Fecica, R. L. Goyan, J. L. Buchholz, C. Campbell, N. M. Kelly D. T. Cramb (2006) Photobleaching kinetics of optically trapped multilamellar vesicles containing verteporfin using two-photon excitation section sign. Photochem. Photobiol. 82, 152 157. (Pubitemid 43343051)
43. Ambroz, M., A. J. MacRobert, J. Morgan, G. Rumbles, M. S. Foley D. Phillips (1994) Time-resolved fluorescence spectroscopy and intracellular imaging of disulphonated aluminium phthalocyanine. J. Photochem. Photobiol. B, Biol. 22, 105 117. (Pubitemid 24075165)
44. Cubeddu, R., A. Pifferi, P. Taroni, A. Torricelli, G. Valentini, D. Comelli, C. D'Andrea, V. Angelini G. Canti (2000) Fluorescence imaging during photodynamic therapy of experimental tumors in mice sensitized with disulfonated aluminum phthalocyanine. Photochem. Photobiol. 72, 690 695.
45. Babilas, P., V. Schacht, G. Liebsch, O. S. Wolfbeis, M. Landthaler, R. M. Szeimies C. Abels (2003) Effects of light fractionation and different fluence rates on photodynamic therapy with 5-aminolaevulinic acid in vivo. Br. J. Cancer 88, 1462 1469. (Pubitemid 36606432)
46. Foster, T. H., D. F. Hartley, M. G. Nichols R. Hilf (1993) Fluence rate effects in photodynamic therapy of multicell tumor spheroids. Cancer Res. 53, 1249 1254. (Pubitemid 23097097)
47. Zhou, X., B. W. Pogue, B. Chen, E. Demidenko, R. Joshi, J. Hoopes T. Hasan (2006) Pretreatment photosensitizer dosimetry reduces variation in tumor response. Int. J. Radiat. Oncol. Biol. Phys. 64, 1211 1220. (Pubitemid 43295319)
48. Busch, T. M., S. M. Hahn, E. P. Wileyto, C. J. Koch, D. L. Fraker, P. Zhang, M. Putt, K. Gleason, D. B. Shin, M. J. Emanuele, K. Jenkins, E. Glatstein S. M. Evans (2004) Hypoxia and Photofrin uptake in the intraperitoneal carcinomatosis and sarcomatosis of photodynamic therapy patients. Clin. Cancer Res. 10, 4630 4638. (Pubitemid 38955512)
49. Bellnier, D. A., W. R. Greco, G. M. Loewen, H. Nava, A. R. Oseroff T. J. Dougherty (2006) Clinical pharmacokinetics of the PDT photosensitizers porfimer sodium (Photofrin), 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (Photochlor) and 5-ALA-induced protoporphyrin IX. Lasers Surg. Med. 38, 439 444.